Paul Oakley

573 total citations
8 papers, 455 citations indexed

About

Paul Oakley is a scholar working on Pharmacology, Spectroscopy and Organic Chemistry. According to data from OpenAlex, Paul Oakley has authored 8 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Spectroscopy and 2 papers in Organic Chemistry. Recurrent topics in Paul Oakley's work include Analytical Chemistry and Chromatography (3 papers), Chromatography in Natural Products (2 papers) and Alzheimer's disease research and treatments (2 papers). Paul Oakley is often cited by papers focused on Analytical Chemistry and Chromatography (3 papers), Chromatography in Natural Products (2 papers) and Alzheimer's disease research and treatments (2 papers). Paul Oakley collaborates with scholars based in United Kingdom, United States and Switzerland. Paul Oakley's co-authors include Christopher T. Brain, Euan R. Kay, Laure Hitzel, Mark S. Shearman, Duncan Shaw, Martin Teall, G. John Langley, Timothy Harrison, José L. Castro and Amaury Cazenave‐Gassiot and has published in prestigious journals such as Journal of Chromatography A, Tetrahedron Letters and Bioorganic & Medicinal Chemistry Letters.

In The Last Decade

Paul Oakley

8 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Oakley United Kingdom	8	254	118	90	75	59	8	455
Taro Yamashita Japan	11	64 0.3×	102 0.9×	195 2.2×	56 0.7×	26 0.4×	19	493
Michael Chlenov United States	10	64 0.3×	103 0.9×	85 0.9×	47 0.6×	36 0.6×	21	263
Dauh‐Rurng Wu United States	10	66 0.3×	240 2.0×	132 1.5×	114 1.5×	113 1.9×	31	380
Jennifer Tavares Jacon Freitas Brazil	10	62 0.2×	47 0.4×	51 0.6×	18 0.2×	13 0.2×	20	325
János Kóti Hungary	12	198 0.8×	37 0.3×	85 0.9×	18 0.2×	61 1.0×	27	296
Rose Mathew United States	10	162 0.6×	44 0.4×	120 1.3×	25 0.3×	23 0.4×	13	270
John J. Venit United States	10	166 0.7×	73 0.6×	131 1.5×	28 0.4×	30 0.5×	16	359
Kinfe K. Redda United States	13	333 1.3×	18 0.2×	120 1.3×	6 0.1×	8 0.1×	57	481
H. Scott Wilkinson United States	13	278 1.1×	32 0.3×	127 1.4×	5 0.1×	21 0.4×	15	422
Mohamed A. Abu El‐Enin Egypt	10	257 1.0×	36 0.3×	156 1.7×	49 0.7×	11 0.2×	15	348

Countries citing papers authored by Paul Oakley

Since Specialization

Citations

This map shows the geographic impact of Paul Oakley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Oakley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Oakley more than expected).

Fields of papers citing papers by Paul Oakley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Oakley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Oakley. The network helps show where Paul Oakley may publish in the future.

Co-authorship network of co-authors of Paul Oakley

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Oakley. A scholar is included among the top collaborators of Paul Oakley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Oakley. Paul Oakley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Brown, Zarin, Steven J. Charlton, Brian J. Cox, et al.. (2014). The discovery of potent, orally bioavailable pyrimidine-5-carbonitrile-6-alkyl CXCR2 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 24(15). 3285–3290. 15 indexed citations

Cazenave‐Gassiot, Amaury, Robert J. Boughtflower, Laure Hitzel, et al.. (2009). Effect of increasing concentration of ammonium acetate as an additive in supercritical fluid chromatography using CO2–methanol mobile phase. Journal of Chromatography A. 1216(36). 6441–6450. 65 indexed citations

Boughtflower, Robert J., Laure Hitzel, S. J. Lane, et al.. (2008). Ionisation in the absence of high voltage using supercritical fluid chromatography: a possible route to increased signal. Rapid Communications in Mass Spectrometry. 22(22). 3673–3682. 10 indexed citations

Cazenave‐Gassiot, Amaury, Robert J. Boughtflower, Laure Hitzel, et al.. (2007). Prediction of retention for sulfonamides in supercritical fluid chromatography. Journal of Chromatography A. 1189(1-2). 254–265. 11 indexed citations

Brondz, Ilia, Dag Ekeberg, David S. Bell, et al.. (2006). Nature of the main contaminant in the drug primaquine diphosphate: SFC and SFC–MS methods of analysis. Journal of Pharmaceutical and Biomedical Analysis. 43(3). 937–944. 39 indexed citations

Teall, Martin, Paul Oakley, Timothy Harrison, et al.. (2005). Aryl sulfones: a new class of γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(10). 2685–2688. 98 indexed citations

Churcher, Ian, Dirk Beher, Jonathan D. Best, et al.. (2005). 4-Substituted cyclohexyl sulfones as potent, orally active γ-secretase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(2). 280–284. 61 indexed citations

Brain, Christopher T., et al.. (1999). Novel procedure for the synthesis of 1,3,4-oxadiazoles from 1,2-diacylhydrazines using polymer-supported Burgess reagent under microwave conditions. Tetrahedron Letters. 40(16). 3275–3278. 156 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact